Press Release

visiongain

Top Companion Diagnostic Companies: Competitive Analysis 2023

February 21st, 2021 3:54 PM

A myriad of pharmaceutical and diagnostic companies are now entering the highly attractive market of companion diagnostics, many of them entering into collaborations for developing a combination product. Apart from the well-known pharmaceutical and diagnostic companies, some small, niche-companies are also focusing on companion diagnostic development. At present, competition is largely dependent on the ability to collaborate with biotechnology and pharmaceutical companies to develop and commercialise these tests for their therapeutic drugs and drug candidates. The number of partnerships between the two industries will keep expanding as most pharmaceutical companies do not have an in-house diagnostic capability for either the development of a companion diagnostic or the commercialisation of the test once the drug is approved.

Top Companion Diagnostic Companies: Competitive Analysis 2013-2023 analyses the top 12 companies involved in the companion diagnostics market. This report also provides our sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis. There are 125 tables and figures included. The result is a comprehensive market, and industry-centred study, with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global companion diagnostics market will reach $19.3bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 – all highlighting key business opportunities.

Why you should buy Top Companion Diagnostic Companies: Competitive Analysis 2013-2023

• 137 pages of comprehensive analysis
• 1 Exclusive Visiongain interviews with experts from-
– Myriad Genetics
• 125 tables, charts, and graphs
• Companion diagnostic market forecast between 2012-2023
• 2 companion diagnostic submarket forecasts from 2012-2023
– Theranostics
– Other companion diagnostics
• A SWOT analysis
• Several leading companies identified and 12 profiled –
Roche, Dako, QIAGEN, Abbott, Life Technologies, LabCorp, Genomic Health, MDxHealth, bioMerieux, Johnson and Johnson, Siemens and Myriad Genetics

Press Release

  • Recent
  • Popular
  • Comments
  • Cryotherapy Industry Growth Prospect, Future Trend, Comprehensive Analysis and Forecasts 2021 to 2026

    Learn More
  • Malaria Vaccines Industry 2021 In-depth Industry Analysis By Types, Applications

    Learn More
  • Scaffold Technology Industry 2026 : Detailed survey of the key competitors and the leading players

    Learn More
  • Healthcare IT Industry 2021 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players

    Learn More
  • IBM Watson Services Market 2021-2028: Industry Analysis and Forecast

    Learn More
  • Lithium-Ion Battery Cathode Market Regional Analysis, Competitive Landscape and Forecast to 2028

    Learn More
  • Cell Banking Outsourcing Industry Opportunities Future Guidelines Value Chain Forecast To 2025

    Learn More
  • Visiongain Publishes Directed Energy Weapons (DEW) Market Report 2021-2031

    Learn More